Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.41M Sell
224,786
-3,195
-1% -$83.6K 0.06% 207
2026
Q1
$6.4M Sell
227,981
-1,916
-0.8% -$51K 0.08% 183
2025
Q4
$5.72M Buy
229,897
+129
+0.1% +$3.25K 0.07% 198
2025
Q3
$5.85M Sell
229,768
-2,660
-1% -$65.7K 0.08% 195
2025
Q2
$5.63M Buy
+232,428
New +$5.42M 0.08% 193

Other funds holding PFE

Midwest Trust's PFE Position: Q2 2026 in Review

Midwest Trust reduced its Pfizer (PFE) stake by 1.4% in Q2 2026, selling an estimated $83.6K and leaving 224,786 shares worth $5.41M. The position accounts for 0.06% of the portfolio, ranked #207.

Midwest Trust first reported a position in PFE in Q2 2025 and has held it in 5 quarters since. The position peaked at $6.4M in Q1 2026. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Midwest Trust held 224,786 shares of Pfizer worth $5.41M as of Q2 2026.
  • Midwest Trust sold 3,195 Pfizer shares in Q2 2026, an estimated $83.6K.
  • Pfizer made up 0.06% of Midwest Trust's portfolio in Q2 2026, its #207 holding.
  • Midwest Trust first reported a position in Pfizer in Q2 2025 and has held it in 5 quarters since.
  • Midwest Trust's Pfizer position peaked at $6.4M in Q1 2026.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Midwest Trust's 13F filing for Q2 2026, filed 5 Aug 2026.